Antibodies against peptidyl arginine deiminase-4 (PAD-4), an enzyme responsible for citrullination, was originally detected in 36-42% or RA patients with high specificity (51), and gained interest as anti-PAD-4 could inhibit citrullination of fibrinogen (52). The gene discussed is PADI4; the disease is rheumatoid arthritis.